Abstract
Cigarette smoking is a well-established risk factor for stroke due to its contribution to atherosclerosis. This study utilized data from the Kyoto Stroke Registry (KSR) spanning April 1997 to March 2020 to investigate the relationship between smoking history and the age at which stroke occurs.
The study focused on stroke patients registered in the KSR, categorizing them into four groups based on their smoking history: those with no smoking history, individuals who quit smoking more than one year ago, those who smoked fewer than 20 cigarettes per day, and those who smoked more than 20 cigarettes per day. The primary objective was to compare the age at which stroke onset occurred among these groups, employing statistical analysis through a Student t-test to identify significant differences.
After excluding patients with missing smoking status information, the analysis involved 30,491 stroke patients. The results revealed a noteworthy association: individuals with a smoking history, particularly heavy smokers, experienced a significantly younger age at stroke onset compared to those who had never smoked. Moreover, the study found that quitting smoking for more than one year was linked to a later onset of stroke compared to continuing to smoke. This observation held true even among those who smoked less than 20 cigarettes per day. Furthermore, the study’s findings remained consistent across all stroke types, including cerebral infarction, cerebral hemorrhage, and subarachnoid hemorrhage, regardless of gender.
In conclusion, this comprehensive analysis of the KSR data reinforces the well-established notion that smoking history plays a critical role in the timing of stroke onset. Importantly, it underscores the potential benefits of smoking cessation, as well as the avoidance of smoking altogether, in reducing the risk of stroke. These findings carry significant implications for public health initiatives aimed at stroke prevention and emphasize the pivotal role of smoking cessation programs in mitigating the risk of stroke-associated morbidity and mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the Japan Medical Association.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
All authors declare no conflicts of interest.
hiromi_n{at}mxt.mesh.ne.jp
Data Availability
Data is managed by the Kyoto Medical Association. Please submit a request for access, including your reasons. If your request is approved, you will be granted access.
